The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Alpa Laboratories Ltd

Alpa Laboratories Ltd

BSE 532878 · NSE ALPA · ISIN INE385I01010 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹61.29

-0.68%

BSE close, 28 August 2026

Market cap

₹128.96 cr

2.1 cr shares · Micro cap

Free float

₹55.21 cr

as published

P/E · P/B

29.5× · 0.74×

EPS ₹2.08 · BV ₹82.82

FY25-26 rev / PAT

105.81 / 14.95

₹ cr, as filed

Filings, window

11

4 selected · 36%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹46.00 52-WK HIGH ₹100.00 ₹61.29 28% of range
Against 52-week high-38.7%
Against 52-week low+33.2%
Day change-0.68%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹2.08
Price / earnings29.47×
Price / book0.74×
Book value — derived, price ÷ P/B₹82.82
Return on equity2.50%
Operating margin7.82%
Net margin4.34%

Consistency check

P/B ÷ P/E, which must equal ROE
2.51%
ROE as published
2.50%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 23.93 1.04 0.52 7.82% 4.34%
Mar-26 · Q 31.40 1.36 0.64 10.92% 4.32%
FY25-26 105.81 14.95 6.69 17.98% 14.13%

Quarter on quarter

Revenue, quarter on quarter
-23.8%
Net profit, quarter on quarter
-23.5%
Operating margin, quarter on quarter
-310 bps

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
KMP2
Change in Management1
Results1
Selected sub-total4
Procedural
General2
AGM / EGM1
Annual Report1
Board Meeting1
Book Closure1
Trading Window1
Procedural sub-total7
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 4 selected · busiest 2026-09-07

Filing rhythm · the twelve most recent

2026-07-222026-09-30

SelectedProcedural

Filings

11 in the window · 2 earlier on record

  1. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Summary of Proceedings of 38th Annual General Meeting of the Company held on Wednesday, 30th September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI ....

    AGM/EGM / AGM View filing →

  2. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of closure of trading window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 17 September 2026 ·

    KMP

    Appointment of Company Secretary and Compliance Officer

    Appointment of Ms. Diksha Jaswani, as a company secretary cum compliance officer of the company w.e.f September 17,2026.

    Company Update / Appointment of Company Secretary / Compliance Officer View filing →

  4. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the Financial Year Ended March 31,2026

    Others / Reg. 34 (1) Annual Report View filing →

  5. 7 September 2026 ·

    Book Closure

    Fixes Book Closure For The Purpose Of AGM.

    Intimation of Book Closure for the Purpose of 38th AGM.

    Corp. Action / Book Closure View filing →

  6. 7 September 2026 ·

    Change in Management

    Change in Management

    Appointment of Mrs. Radhika Biyani as an Independent Director.

    Company Update / Change in Management View filing →

  7. 13 August 2026 ·

    Results

    Results For The Quarter Ended June 2026

    Results for the quarter ended June 2026 along with the approval of Notice of 38th Annual General Meeting

    Result / Financial Results View filing →

  8. 11 August 2026 ·

    General

    CLARIFICATION ON BOARD MEETING

    CLARIFICATION ON BOARD MEETING DATE WITH RESPECT TO THE EARLIER SUBMISSION

    Company Update / General View filing →

  9. 4 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30Th June, 2026

    Alpa Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Standalone and Consolidated ....

    Board Meeting / Board Meeting View filing →

  10. 29 July 2026 ·

    General

    Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For Materiality Of Information

    Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

    Company Update / General View filing →

  11. 22 July 2026 ·

    KMP

    Cessation

    Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 , we hereby inform you that Ms. Jyoti Jain has ceased to be an ....

    Company Update / Cessation View filing →

RSS feed for Alpa Laboratories Ltd · the 50 most recent filings